S 191New Jersey

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

In committee

Jan 9, 2024: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Follow this bill Ratifi